TIS 0.00% 0.0¢ tissue therapies limited

need for product, page-25

  1. 472 Posts.
    lightbulb Created with Sketch. 12
    Roy, this is an interesting article comparing EU CE Mark approval as opposed to FDA approval:

    http://www.mdtmag.com/Articles/2012/02/Which-Way-to-Go--CE-Mark-or-FDA-Approval-/

    I agree with you. If you were about to have your foot lopped off wouldn't you do everything you could to get on a plane to Europe and get a few Vitrogro treatments??

    The natural progression of that is: wouldn't there be an enormous pressure on the US Government to stop people leaving the country to get a simple treatment which is being held up by bureaucracy?

    Rev
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.